|1||Active, not recruiting||
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors
Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors
† Study has passed its completion date and status has not been verified in more than two years.